Bill

Bill > HB811


MD HB811

MD HB811
Hospitals - Testing for Fentanyl (The Josh Siems Act)


summary

Introduced
02/08/2023
In Committee
03/31/2023
Crossed Over
03/20/2023
Passed
04/05/2023
Dead
Signed/Enacted/Adopted
05/03/2023

Introduced Session

2023 Regular Session

Bill Summary

AN ACT concerning Hospitals - Overdoses - Testing for Fentanyl (The Josh Siems Act) FOR the purpose of requiring the emergency department of a hospital to conduct a rapid include testing for fentanyl as part of a urine drug test for fentanyl in patients with a known or suspected drug overdose if a toxicology report is requested by a treating health care provider screening; and generally relating to fentanyl testing for hospital patients with a known or suspected overdose. BY adding to Article - Health - General Section 19-308.9 Annotated Code of Maryland (2019 Replacement Volume and 2022 Supplement)

AI Summary

This bill, known as the "Josh Siems Act," requires hospitals in Maryland to include testing for fentanyl as part of the urine drug screening for patients who are being treated for a known or suspected drug overdose. The bill mandates that if the urine drug screening detects fentanyl, the hospital must report the deidentified test results to the state's designated health information exchange. The bill provides an exception for hospitals that do not have the necessary chemical analyzer equipment to conduct the fentanyl testing. Additionally, the bill does not affect any existing state laws that provide civil or criminal immunity to individuals who are in need of medical assistance after using alcohol or drugs, or to those who assist others in such situations.

Committee Categories

Budget and Finance, Health and Social Services

Sponsors (30)

Last Action

Approved by the Governor - Chapter 325 (on 05/03/2023)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...